Cystinosis Research Foundation
Profile Not Current (Last updated:
Jan 09, 2026
)
Current Fiscal Year
Fiscal Year Start Date: July 1, 2024
Fiscal Year End Date: June 30, 2025
Projected Revenue: $2,825,000
Projected Expense: $2,900,888
Revenue vs. Expense ($)
Expense Breakdown: 2024 (%)
| Administration Expense | 0.0% |
| Program Expense | 0.0% |
| Fundraising Expense | 0.0% |
Expense Breakdown: 2023 (%)
| Administration Expense | 8.3% |
| Program Expense | 80.9% |
| Fundraising Expense | 10.8% |
Expense Breakdown: 2022 (%)
| Administration Expense | 6.5% |
| Program Expense | 83.5% |
| Fundraising Expense | 10.1% |
990 Tax Form Newest 990 Year opens each June
Tax Year 2024 Form 990 (Fiscal Year ending in 2024)
Tax Year 2023 Form 990 (Fiscal Year ending in 2023)
Download
Tax Year 2022 Form 990 (Fiscal Year ending in 2022)
Download
Tax Year 2021 Form 990 (Fiscal Year ending in 2021)
Download
Prior Three Years Total Revenue and Expense Totals
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Revenue | $3,187,305 | $3,244,975 | $3,589,447 |
| Total Expenses | $4,157,212 | $2,871,720 | $3,072,713 |
Prior Three Years Revenue Sources
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Foundation and Corporation Contributions | - | $2,858,400 | $2,584,510 |
| Government Contributions | - | - | - |
| Federal | - | - | - |
| State | - | - | - |
| Local | - | - | - |
| Unspecified | - | - | - |
| Individual Contributions | - | - | - |
| Indirect Public Support | - | - | - |
| Earned Revenue | - | - | - |
| Investment Income, Net of Losses | - | $350,852 | $668,443 |
| Membership Dues | - | - | - |
| Special Events | - | $35,723 | $336,494 |
| Revenue In-Kind | - | - | - |
| Other Revenue | - | $459,927 | $1,119,865 |
Prior Three Years Expense Allocations by Type
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Program Expense | - | $2,322,732 | $2,565,114 |
| Administration Expense | - | $238,179 | $198,246 |
| Fundraising Expense | - | $310,809 | $309,353 |
| Payments to Affiliates | - | - | - |
| Total Revenue/Total Expenses | 0.77 | 1.13 | 1.17 |
| Program Expense/Total Expenses | - | 81% | 83% |
| Fundraising Expense/Total Revenue | - | 10% | 9% |
Prior Three Years Assets and Liabilities
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $10,415,384 | $10,305,666 | $10,168,657 |
| Current Assets | - | $6,058,199 | $6,279,343 |
| Long-Term Liabilities | - | - | - |
| Current Liabilities | - | $1,643,150 | $1,942,498 |
| Total Net Assets | $7,746,091 | $8,662,516 | $8,226,159 |
Short Term Solvency
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets/Current Liabilities | - | 3.69 | 3.23 |
Long Term Solvency
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Long Term Liabilities/Total Assets | - | - | - |
Endowment/Capital Campaigns
Are you currently in a Capital Campaign? No
CONTACT
Cystinosis Research Foundation
19200 Von Karman Avenue
Suite 920
Irvine, CA 92612
Phone: 949-223-7610